Johnson & Johnson is working to develop modified variations of its COVID-19 vaccine which may be wanted to guard in opposition to virus variants, a report stated.
“We’re working on a number of subsequent generations of vaccines,” J&J Chief Govt Alex Gorsky stated Thursday throughout a web-based dialogue, in keeping with The Wall Avenue Journal.
Gorsky expressed optimism that its present vaccine may supply some safety in opposition to new COVID-19 strains.
However, he stated, “Now we have to be ready,” the newspaper reported. “We must always put together for the worst and hope for one of the best.”
Johnson & Johnson’s single-dose vaccine was authorized by the US Meals and Drug Administration in late February.
The FDA affirmed J&J’s discovering that the vaccine was 66 % efficient total at fending off average and extreme COVID-19 circumstances and 85 % efficient at stopping probably the most severe infections.